Thumbnail Image

Foot-and-mouth disease Minimum Biorisk Management Standards

Course Introduction










Also available in:
No results found.

Related items

Showing items related by metadata.

  • Thumbnail Image
    Other document
    Minimum Biorisk Management Standards (MBRMS) for laboratories working with foot-and-mouth disease virus
    45th General Session of the European Commission for the Control of Foot-and-Mouth Disease (EuFMD)
    2023
    Also available in:
    No results found.

  • Thumbnail Image
    Brochure
    Foot-and-mouth disease laboratory investigation
    Training course
    2022
    Also available in:

    This course is aimed at those working in national or regional foot-and-mouth disease laboratories and involved in carrying out or managing laboratory testing activities. The EuFMD and the World Reference Laboratory for FMD, based at the Pirbright Institute, have partnered to produce this course.
  • Thumbnail Image
    Meeting document
    Minimum biorisk management standards for laboratories working with foot-and-mouth disease virus - Update May 2025
    45th General Session of the European Commission for the Control of Foot-and-Mouth Disease (EuFMD)
    2025
    Also available in:
    No results found.

    This document described a set of precautions to be taken by laboratories working with foot-and-mouth disease (FMD) to avoid an escape of virus, and is regularly updated and adopted at the General Sessions of the EuFMD. This 2025 version was adopted at the May 2025 General Session of the EuFMD.In the 2025 version, "Contingency laboratory" was replaced by "Emergency laboratory", which covers non-continuously working Tier C laboratories established for both FMD outbreaks and other crises. Tier C category II laboratories are FMD emergency laboratories and can in the event of an FMD emergency be part of the contingency plans, as foreseen in Annex XV of Council Directive 2003/85/EC1. FMD emergency laboratories must not work with any infectious FMDV – except for virus that might be present in field samples submitted for FMD diagnosis from the region or country where the laboratory is situated. This means there is no risk of escape unless there is an outbreak in the field – in which case the risk posed by infected holdings by far outweighs any escape risk posed by a laboratory operating according to Tier C. In contrast to the expectations in 2009 and 2013, there is still no fully validated protocol for inactivation of FMD samples on the suspect premises.

Users also downloaded

Showing related downloaded files

No results found.